Vicarious Surgical Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Vicarious Surgical Inc (RBOT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
API endpoints for this dataset
Vicarious Surgical Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Vicarious Surgical Inc | - | - | - | Yes |
| Competitors combined (26) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
RBOT Stock Performance relative to its Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Adagio Medical Holdings inc | 282.9% | Outperformed |
| 2 | Monogram technologies inc | 282.9% | Outperformed |
| 3 | Autonomix Medical Inc | 282.9% | Outperformed |
| 4 | Tenon Medical Inc | 282.9% | Outperformed |
| 5 | Johnson and Johnson | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Vicarious Surgical Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Vicarious Surgical Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Vicarious Surgical Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Vicarious Surgical Inc |
0.11 | - |
 Johnson and Johnson |
694,227.07 | 99,335.00 |
 Intuitive Surgical Inc |
154,665.32 | 12,115.60 |
 Medtronic Plc |
129,782.25 | 37,542.00 |
 Stryker Corp |
120,176.43 | 26,300.00 |
 Edwards Lifesciences Corporation |
61,110.08 | 6,512.50 |
| SUBTOTAL | 1,217,679.68 | 207,691.07 |
Sign in to see all competitors of Vicarious Surgical Inc.
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Vicarious Surgical Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Vicarious Surgical Inc's Competitors Named by the Company
Competitive relationships identified from Vicarious Surgical Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| CMR Surgical Ltd. | Company report | 85% |
| Titan Medical Inc | Company report | 85% |
| Medtronic Plc | Company report | 85% |
| Intuitive Surgical Inc | Company report | 85% |
| Stryker Corp | Company report | 85% |
| Asensus Surgical Inc | Company report | 85% |
| Globus Medical Inc | Company report | 85% |
| Encision Inc | Company report | 85% |
| Smith and Nephew Plc | Company report | 85% |
| Sintx Technologies Inc | Company report | 85% |
| Adagio Medical Holdings inc | Company report | 85% |
| Johnson and Johnson | Company report | 85% |
| Zimmer Biomet Holdings Inc | Company report | 85% |
| Procept Biorobotics Corporation | Company report | 85% |
| Edwards Lifesciences Corporation | Company report | 85% |
| Teleflex Incorporated | Company report | 85% |
| Conmed Corporation | Company report | 85% |
| Medinotec Inc | Company report | 85% |
| Zimvie Inc | Company report | 85% |
| Fuse Medical Inc | Company report | 85% |
| Utah Medical Products Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Vicarious Surgical Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Vicarious Surgical Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Johnson and Johnson | Oncology 29.93 % |
| Medtronic Plc | CARDIOVASCULAR 38.34 % |
| Stryker Corp | MedSurg and Neurotechnology 56.20 % |
| Edwards Lifesciences Corporation | United States 58.74 % |
| Zimmer Biomet Holdings Inc | Americas Segment 63.91 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Vicarious Surgical Inc.
Vicarious Surgical Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Vicarious Surgical Inc | 0 | - | -1,619,885 |
| Johnson and Johnson | 694,227 | 705,504 | 114,311 |
| Intuitive Surgical Inc | 154,665 | 711,803 | 174,578 |
| Medtronic Plc | 129,782 | 395,179 | 55,463 |
| Stryker Corp | 120,176 | 469,643 | 64,696 |
| Edwards Lifesciences Corporation | 61,110 | 407,031 | 62,725 |
| PEERS TOTAL | 1,217,680 | 521,144 | 75,162 |
Sign in to see all peers for Vicarious Surgical Inc.
Vicarious Surgical Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Johnson and Johnson | United States 58.90 % |
| Intuitive Surgical Inc | Geographic Distribution, Foreign 29.66 % |
| Medtronic Plc | United States 49.83 % |
| Stryker Corp | United States 75.92 % |
| Zimmer Biomet Holdings Inc | US 58.44 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Vicarious Surgical Inc.
Vicarious Surgical Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 218 companies in Vicarious Surgical Inc's industry classification, broader than the peer set above. Market cap in millions of $.Vicarious Surgical Inc ranks #0 of 218 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 599, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Intuitive Surgical Inc | 157,173 | 13.12 % |
| 2 | Medtronic Plc | 129,782 | 10.83 % |
| 3 | Stryker Corp | 120,583 | 10.06 % |
| 4 | 3m Company | 97,292 | 8.12 % |
| 5 | Boston Scientific Corporation | 1,234 | 5.2% |
| 6 | Edwards Lifesciences Corporation | 1,234 | 5.2% |
| 7 | Becton Dickinson And Company | 1,234 | 5.2% |
| 8 | Alcon inc | 1,234 | 5.2% |
| 9 | Resmed Inc | 1,234 | 5.2% |
| 10 | Medline Inc | 1,234 | 5.2% |
| 0 | Vicarious Surgical Inc | 0 | 0.00 % |
Market cap and industry share for the rest of Vicarious Surgical Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-11.
Vicarious Surgical Inc's Valuation vs Competitive Position
Valuation multiples vs the Medical Equipment & Supplies industry average (341 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Medical Equipment & Supplies industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 37.0x | - |
| EV / EBITDA | - | 17.4x | - |
| P/B | 1.0x | 4.7x | -3.7x |
| Return on Equity | -333.19 % | industry aggregate | -341.42 % |
| Return on Invested Capital | -118.08 % | -6.49 % (avg) | -111.59 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Vicarious Surgical Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|
| Revenue Growth | - | - | - | - |
| Operating Margin | - | - | - | - |
| Return on Invested Capital | - | -29.67 % | -39.93 % | -94.72 % |
| P/E | - | 95.8x | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Vicarious Surgical Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 599 (see Industry Market Structure & Concentration above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Vicarious Surgical Inc's dedicated Suppliers and Customers pages, not here.
Vicarious Surgical Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Return on equity 341.4 points below the industry aggregate.
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-2.1% annualized).
Methodology: see Methodology: SWOT Analysis.
Vicarious Surgical Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Vicarious Surgical Inc | 0.71 | 3.73 | 0.02 |
| Johnson and Johnson | 0.36 | 1.04 | 0.60 |
| Intuitive Surgical Inc | 1.33 | 4.37 | - |
| Medtronic Plc | 0.15 | 2.10 | 0.57 |
| Stryker Corp | 0.50 | 2.08 | 0.65 |
| Edwards Lifesciences Corporation | 1.74 | 4.14 | 0.06 |
Sign in to see all peers for Vicarious Surgical Inc.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Vicarious Surgical Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Vicarious Surgical Inc | Q1 2026 | - | - |
| Johnson and Johnson | Q3 2026 | +5.9 % | -95.9 % |
| Intuitive Surgical Inc | Q3 2026 | +32.7 % | -26.3 % |
| Medtronic Plc | Q2 2026 | +13.7 % | +41.3 % |
| Stryker Corp | Q3 2026 | +7.6 % | -12.3 % |
| Edwards Lifesciences Corporation | Q2 2026 | +13.7 % | -27.2 % |
| PEERS TOTAL | +8.0 % | -39.2 % |
Sign in to see all peers for Vicarious Surgical Inc.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Vicarious Surgical Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Vicarious Surgical Inc | Q1 2026 | - | +80.0 % |
| Johnson and Johnson | Q3 2026 | +10.9 % | +17.7 % |
| Intuitive Surgical Inc | Q3 2026 | +14.5 % | +7.3 % |
| Medtronic Plc | Q2 2026 | +13.8 % | -0.2 % |
| Stryker Corp | Q3 2026 | +3.0 % | +26.7 % |
| Edwards Lifesciences Corporation | Q2 2026 | +14.1 % | +35.7 % |
Sign in to see all peers for Vicarious Surgical Inc.
Vicarious Surgical Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Vicarious Surgical Inc | - | - | - |
| Johnson and Johnson | 8.06% | 10.53% | 19.55% |
| Intuitive Surgical Inc | 14.71% | 16.30% | 16.99% |
| Medtronic Plc | 5.71% | 6.46% | 10.64% |
| Stryker Corp | 7.66% | 8.63% | 15.61% |
| Edwards Lifesciences Corporation | 7.41% | 8.39% | 9.65% |
Sign in to see all peers for Vicarious Surgical Inc.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Vicarious Surgical Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Vicarious Surgical Inc | - | - |
| Johnson and Johnson | 42.89 | 6.99 |
| Intuitive Surgical Inc | 53.38 | 12.77 |
| Medtronic Plc | 297.03 | 3.46 |
| Stryker Corp | 33.27 | 4.57 |
| Edwards Lifesciences Corporation | 60.91 | 9.38 |
| PEERS AVERAGE | 40.71 | 5.86 |
Sign in to see all peers for Vicarious Surgical Inc.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.